As many of you know, the IU School of Medicine is the second-largest medical school in the nation in terms of number of medical students enrolled — more than 1,300 now. But we also have a good number of doctoral students — just over 210, plus 46 enrolled in our M.D./Ph.D. program.
These are talented folks and many of them, it’s fair to say, have an eye on a career in academic research — just like their mentors. In fact, that’s what we’ve always done — and do — as mentors: We train these young doctoral students to be just like us. And these days, amid ever-tightening research funding and what many call a Ph.D. “glut,” more of the same is a disservice.
So starting with the spring 2015 semester, IUSM doctoral students will have the opportunity to pursue a new minor in the Business of Biomedical Sciences. This program was just approved by the IUPUI Graduate Office and IUPUI Executive Vice President Nasser Paydar.
Under the leadership of Randy Brutkiewicz, associate dean for graduate studies, we’ve put together a nine-credit minor incorporating existing courses from the schools of business, law and medicine as well as an eight-week internship. The program includes such courses as Translational Research and Entrepreneurship and Intellectual Property of Pharmaceutical Products and Medical Devices.
Why do this? Whatever you think about the causes, cures or even existence of a Ph.D. glut, some of our grads have and will go on to careers outside academia. But that world, like ours, is changing fast and we want to help provide those grads with business and entrepreneurial tools that will be increasingly important whether they are working in health care systems, big pharma, biotech startups or careers grappling with intellectual property issues.
If you have questions, comments or suggestions, post them here or send a note to Randy at email@example.com.